logo
  • About
    • About VGXI
    • Leadership
    • VGXI Mission
    • Awards
    • FAQ
    • Careers
  • Services
    • Manufacturing Services
    • cGMP Plasmid
    • HD Plasmid
    • Pre-Clinical Plasmid
    • Additional Services
  • VGXI Process
    • VGXI Manufacturing Process
    • Analytical Testing
    • Quality Systems
  • News and Events
    • News
    • Events
  • Contact Us

VGXI Official Statement Regarding COVID-19

VGXI Official Statement Regarding COVID-19

April 17, 2020

A Message from VGXI Regarding the Coronavirus (COVID-19) Outbreak and VGXI Actions

LAST UPDATED February 12, 2021

To our Valued Clients and Business Partners,

VGXI recognizes your concerns regarding the potential impact of the coronavirus outbreak on our products and services. VGXI is actively monitoring the situation and will continue to provide updates as new information becomes available.

At this time, the VGXI facility is continuing operations and manufacturing activities are proceeding as scheduled. The materials and planning teams are in constant contact with our suppliers to proactively identify and address potential impacts to incoming materials or equipment. The VGXI Leadership Team has also evaluated and implemented appropriate measures to ensure the safety of our employees and business continuity.

Specifically, VGXI is taking the following precautionary steps:

  • VGXI has increased communications with all suppliers and is closely monitoring changes in lead times
  • VGXI has identified critical raw materials and secured additional on-site inventory, as needed
  • VGXI has taken steps to manage the supply for critical PPE including gowning materials
  • VGXI has increased internal safety precautions and policies for elevated hygiene
  • VGXI has increased the frequency of facility cleaning and disinfection for both process and common areas
  • VGXI has implemented policies to promote social distancing and remote work for employees where possible
  • VGXI has implemented a mask policy within the facility

VGXI received notice from some of its testing vendors of potential impacts to testing timelines as they take precautionary measures to minimize person to person contact while maintaining operations. As information becomes available, VGXI will promptly communicate possible changes to disposition timelines to specific clients.

Our top priority is to continue delivering the highest quality DNA products and services while ensuring the security and safety of our team. VGXI will continue to closely monitor the coronavirus situation and keep our clients and partners informed of any changes to the current operation status.

Thank you for your continued partnership. Please Contact Us if you have any questions.

Sincerely,
Dorothy Peterson
Chief Operating Officer
VGXI, Inc.

Filed Under: Blog, Events, Media, News, Sticky Post

Archives

  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007

Get In Touch

We would like to hear from you. Contact us today to ask a question or request a quote for our plasmid DNA manufacturing services.

CONTACT US


logo

VGXI, INC.

2700 Research Forest Drive, Suite 180, The Woodlands, Texas 77381, USA

281-296-7300

© 2020 VGXI, Inc. All Rights Reserved. | Terms and Conditions | Privacy Policy | Resources | Careers